These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38797808)

  • 1. Impella support for refractory cardiogenic shock accompanied by diabetic ketoacidosis: a case report.
    Nakagaito M; Nakamura M; Imamura T; Ueno H; Kinugawa K
    J Artif Organs; 2024 May; ():. PubMed ID: 38797808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and Design of JenaMACS-Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock.
    Haertel F; Lenk K; Fritzenwanger M; Pfeifer R; Franz M; Memisevic N; Otto S; Lauer B; Weingärtner O; Kretzschmar D; Dannberg G; Westphal J; Baez L; Bogoviku J; Schulze PC; Moebius-Winkler S
    J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report.
    Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y
    World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report.
    Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG
    Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report.
    Yeo SM; Park H; Paek JH; Park WY; Han S; Park SB; Jin K
    Medicine (Baltimore); 2019 Jan; 98(3):e14150. PubMed ID: 30653152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-glucose cotransporter 2 inhibitor-induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction.
    Cavka L; Bencak Ferko U; Pitz N; Trpkovski Z; Lainscak M
    ESC Heart Fail; 2021 Aug; 8(4):2631-2636. PubMed ID: 34102028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management.
    Xu B; Li S; Kang B; Zhou J
    Cardiovasc Diabetol; 2022 May; 21(1):83. PubMed ID: 35614469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports.
    Altowayan WM
    Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
    Andrews TJ; Cox RD; Parker C; Kolb J
    J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory Support - Literature Review and Case-Based Discussion.
    Sharma S; Ruiz J; Paghdar S; Desai S; Goswami R
    Transplant Proc; 2023 Dec; 55(10):2462-2469. PubMed ID: 37980253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle.
    Josiassen J; Helgestad OKL; Udesen NLJ; Banke A; Frederiksen PH; Hyldebrandt JA; Schmidt H; Jensen LO; Hassager C; Ravn HB; Møller JE
    Intensive Care Med Exp; 2020 Aug; 8(1):41. PubMed ID: 32785808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk catheter ablation of refractory atrial fibrillation using Impella CP in a patient with cardiogenic shock.
    Osei K; Taskesen T; Hounshell T; Meyers J
    Pacing Clin Electrophysiol; 2020 Oct; 43(10):1205-1209. PubMed ID: 32790098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
    Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
    Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
    Ebert D; Mungard N; Mensch A; Homeister L; Willsch J; Ibe R; Baust H; Stiller M; Rebelo A; Ukkat J; Rigopoulos AG; Weber E; Bucher M; Noutsias M
    BMC Cardiovasc Disord; 2021 Nov; 21(1):528. PubMed ID: 34743690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "TIDE"-Algorithm for the Weaning of Patients With Cardiogenic Shock and Temporarily Mechanical Left Ventricular Support With Impella Devices. A Cardiovascular Physiology-Based Approach.
    Tschöpe C; Spillmann F; Potapov E; Faragli A; Rapis K; Nelki V; Post H; Schmidt G; Alogna A
    Front Cardiovasc Med; 2021; 8():563484. PubMed ID: 33681302
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of preoperative sodium-glucose cotransporter 2 inhibitors on the incidence of perioperative metabolic acidosis: A retrospective cohort study.
    Iwasaki Y; Sasabuchi Y; Horikita S; Furukawa T; Shiotsuka J; Lefor AK; Sanui M
    BMC Endocr Disord; 2022 Aug; 22(1):209. PubMed ID: 35987618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report.
    Wang KM; Isom RT
    Kidney Med; 2020; 2(2):218-221. PubMed ID: 32734242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications.
    Kasbawala K; Stamatiades GA; Majumdar SK
    Am J Case Rep; 2020 Jun; 21():e921536. PubMed ID: 32483108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.